ATE331037T1 - Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff - Google Patents

Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff

Info

Publication number
ATE331037T1
ATE331037T1 AT96912605T AT96912605T ATE331037T1 AT E331037 T1 ATE331037 T1 AT E331037T1 AT 96912605 T AT96912605 T AT 96912605T AT 96912605 T AT96912605 T AT 96912605T AT E331037 T1 ATE331037 T1 AT E331037T1
Authority
AT
Austria
Prior art keywords
nucleic acid
frpb
acid molecule
isolated
corresponding vaccine
Prior art date
Application number
AT96912605T
Other languages
English (en)
Inventor
P Fredrick Sparling
Margaret Beucher
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE331037T1 publication Critical patent/ATE331037T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96912605T 1995-04-07 1996-04-08 Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff ATE331037T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41896495A 1995-04-07 1995-04-07

Publications (1)

Publication Number Publication Date
ATE331037T1 true ATE331037T1 (de) 2006-07-15

Family

ID=23660253

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96912605T ATE331037T1 (de) 1995-04-07 1996-04-08 Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff

Country Status (8)

Country Link
US (3) US6265567B1 (de)
EP (1) EP0830456B1 (de)
JP (1) JP3797490B2 (de)
AT (1) ATE331037T1 (de)
AU (1) AU5537096A (de)
CA (1) CA2217522C (de)
DE (1) DE69636285D1 (de)
WO (1) WO1996031618A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
US6914131B1 (en) 1998-10-09 2005-07-05 Chiron S.R.L. Neisserial antigens
CA2308606A1 (en) * 1997-11-06 1999-05-20 Chiron S.P.A. Neisserial antigens
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
AU3968599A (en) * 1998-04-29 1999-11-16 American Cyanamid Company Vaccines containing recombinant pilin against Neisseria Gonorrhoeae or Neisseria Meningitidis
AU761780B2 (en) * 1998-05-01 2003-06-12 Glaxosmithkline Biologicals Sa Neisseria meningitidis antigens and compositions
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
US6692752B1 (en) 1999-09-08 2004-02-17 Smithkline Beecham Biologicals S.A. Methods of treating human females susceptible to HSV infection
EP1144643A1 (de) * 1999-01-15 2001-10-17 SMITHKLINE BEECHAM BIOLOGICALS s.a. Neisseria meningitidis antigen
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
AU784203B2 (en) * 1999-10-29 2006-02-23 Glaxosmithkline Biologicals S.A. Neisserial antigenic peptides
JP4763210B2 (ja) 2000-02-28 2011-08-31 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル ナイセリアのタンパク質の異種発現
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
EP2255826B1 (de) 2002-08-02 2016-04-13 GlaxoSmithKline Biologicals S.A. Neisseria impfstoffzusammensetzungen die eine kombination von antigenen enthalten
GB0220199D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Mutant protein and refolding method
LT2395073T (lt) 2002-11-01 2017-11-10 Glaxosmithkline Biologicals S.A. Džiovinimo būdas
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
JP5275983B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule

Also Published As

Publication number Publication date
AU5537096A (en) 1996-10-23
DE69636285D1 (de) 2006-08-03
US6265567B1 (en) 2001-07-24
EP0830456A1 (de) 1998-03-25
US20030096368A1 (en) 2003-05-22
JP3797490B2 (ja) 2006-07-19
CA2217522A1 (en) 1996-10-10
WO1996031618A1 (en) 1996-10-10
EP0830456B1 (de) 2006-06-21
JPH11503322A (ja) 1999-03-26
CA2217522C (en) 2011-09-20
US20050271681A1 (en) 2005-12-08
EP0830456A4 (de) 2001-03-14

Similar Documents

Publication Publication Date Title
DE69636285D1 (de) ISOLIERTES FrpB NUKLEINSÄUREMOLEKÜL UND ENTSPRECHENDE IMPFSTOFF
DK0758248T3 (da) Formuleringer til faktor IX
DE69620877D1 (de) Arzneimittelformulierungen für il-12
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
DK1200418T3 (da) Nematodicide trifluorbutener
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
NO983999D0 (no) Peptidimmunogener for vaksinasjon mot og behandling av allergi
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
TR200806259T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
NO990405L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
DE69610627D1 (de) Neuartige peptidderivate
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
CY1105235T1 (el) Συνθεσεις λασοφοξιφενης
DK0705100T3 (da) Terapeutiske substituerede guanidiner
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
DE69331739D1 (de) Neuartige pharmazeutische verwendungen von krill-enzymen
ATE203519T1 (de) Chinolinderivate als antimalariamittel
PT789590E (pt) Imunopotenciacao induzida por quitosano
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
ATE201693T1 (de) Hämoregulierende peptide
AU5163598A (en) Novel hepatitis b inhibitors
DE69619123D1 (de) Hämoregulatorische verbindungen
DK0579765T3 (da) Fremgangsmåde og præparat til behandling af herpes-relaterede sygdomme
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties